Advanced Development of a Universal Influenza Vaccine
- Institution
- VERSATOPE THERAPEUTICS, INC., MA
- Principal investigator
- Christopher Locher
- Funding
- $955K
- Duration
- 2019–2025
Moonbase score
Still being scored
Abstract
To support the advanced development of candidate products for use following the intentional release of or in response to naturally occurring outbreaks of infectious diseases, including emerging infectious diseases. This contract may support formulation and manufacture of the individual vaccine components, as well as stability testing, nonclinical immunogenicity and efficacy testing in animal models, IND enabling GLP toxicology, submission of an IND and clinical safety and efficacy evaluation.
LOADING MOONBASE SCORE
Questions for Versatope Therapeutics, Inc.
Versatope Therapeutics, Inc. hasn't set up its Moonbase portfolio yet, so questions about this research can't be asked here.
Related grants
Same researchers, same topic, scored first.
- NIH · Versatope Therapeutics, Inc.Not yet scored
Recombinant Outer Membrane Vesicles as a Novel Adjuvant for a Malaria Vaccine
Christopher Locher · $1.0M · 2023–2026
- NIH · Duke UniversityNot yet scored
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
Kevin Saunders · $99K · 2022–2026
- NIH · Immunartes LlcNot yet scored
Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases
Vilasack Thammavongsa · $211K · 2022–2027